Real-world Chinese medicine treatment for chikungunya fever
Official title: Efficacy and Safety of Chinese Medicine in the Treatment of Chikungunya Fever: A Real-World Observational Study
Run by Guangzhou University of Traditional Chinese Medicine · NCT07120724 · Data updated 2026-11-12
This project will try Chinese medicine alone or together with Western medicines to relieve symptoms in people with early chikungunya fever.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Guangzhou University of Traditional Chinese Medicine Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | July 26, 2025 |
| Main results expected | July 26, 2026 |
| Study ends | December 26, 2026 |
| Registry record updated | August 13, 2025 |
| Trial ID | NCT07120724 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People with suspected or confirmed chikungunya fever who can give informed consent and who started treatment within three days of symptom onset are suitable candidates.
✕Probably not a fit
Patients with severe chikungunya or those who present later than three days after symptom onset are unlikely to benefit from the treatments evaluated in this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational real-world project follows people with suspected or confirmed chikungunya who begin treatment within three days of symptom onset. Patients receive whatever treatment their clinician prescribes—traditional Chinese medicine alone, Western medicine alone, or a combination—and researchers record clinical outcomes and safety. No experimental drugs are assigned; the study analyzes routine care at Guangdong Province Hospital of Traditional Chinese Medicine under the sponsorship of Guangzhou University of Traditional Chinese Medicine. The focus is on symptom relief, recovery course, and adverse events to understand how Chinese medicine performs in routine practice.
Why it matters
Potential benefit: If successful, this approach could offer an additional symptom-relief option that shortens recovery and reduces joint pain where no specific antivirals exist.
How similar studies have gone: Some smaller reports and traditional-use data suggest symptom relief with Chinese medicine for viral fevers, but rigorous clinical evidence specifically for chikungunya is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Meets the suspected or confirmed diagnostic criteria for chikungunya fever; 2. Symptom onset ≤3 days before enrollment; 3. Actual prescribed treatment aligns with the study's group assignment (TCM, Western medicine, or combined therapy) 4. Signed informed consent form Exclusion Criteria: 1. Severe chikungunya fever; 2. Participation in another drug clinical trial within the past 3 months; 3. Any other condition deemed by the investigator as unsuitable for enrollment.
Where it's running
-
Guangdong Province Hospital of Tradtional Chinese Medicine
Guangzhou, Guangdong, China Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.